Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,710.00    -300.00 (-4.99%)
Bid:
5,750.00
Ask:
5,765.00
Spread: 15.00 (0.261%)
Market Cap: $1.50t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Disposition

29 Jan 2026 08:24

RNS Number : 9001Q
Samsung Electronics Co. Ld
29 January 2026
 

Decision on Share Disposition

 

1. Number of shares to be disposed

Common

6,729,069

Other

-

2. Price of shares to be disposed (Korean won)

Common

162,400

Other

-

3. Value of shares to be disposed (Korean won)

Common

1,092,800,805,600

Other

-

4. Expected disposition period

Start date

January 30, 2026

End date

January 30, 2026

5. Purpose of disposition

Use of treasury shares as performance based compensation to employees

6. Method of disposition

Open-market (shares)

-

After-hours block trades (shares)

-

Off-market (shares)

-

Other (shares)

6,729,069

7. Counterparties to the disposition

YoungHyun Jun and 51,669 others

8. Consignment investment brokers

Samsung Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

9. Holding status of treasury shares before disposition

Disposition within the allowable distribution of profit (shares)

Common

107,973,999

Ratio (%)

1.8

Other

13,603,461

Ratio (%)

1.7

Other disposition (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

10. Date of board resolution (confirmation date)

January 28, 2026

- Attendance of Independent Directors at the Board of Directors meeting

Present

6

Absent

0

- Attendance of Auditors (Audit Committee members who are not Independent Directors)

-

11. Daily sell order quantity limit

Common

-

Other

-

 

 

 

 

 

12. Other Information to Consider:

- This disclosure relates to the use of treasury shares in the agreed amount as part of the 2025 performance-based compensation to align the interests of shareholders and employees. The conditions for the grant and the number of recipients are as follows:

 

(1) 2025 OPI stock-based compensation

[Grant conditions] The number of shares to be granted will be determined based on the agreed upon amount and the market price.(subject to one-year transfer restriction)

[Number of persons eligible for grant] 51,647

 

(2) Individually-agreed LTI stock-based compensation

[Grant conditions] The agreed number of shares will be granted based on the market price at the time of payment

[Number of persons eligible for grant] 80

- The above details are subject to change within the scope approved by the Board, depending on the number of recipients at the time of the grant and changes in the stock price

- In Item 1 above, the number of shares to be disposed (Korean won) is based on the closing price on the day of the Board's resolution (January 28, 2026)

- In Item 2 above, the price of shares to be disposed (Korean won) is based on the closing price on the day of the Board's resolution (January 28, 2026)

- In Item 3 above, the value of shares to be disposed (Korean won) was calculated by multiplying the number of shares to be disposed by the closing price on the day of board resolution. The actual number of shares disposed of, the stock price, and the total disposal amount may change depending on stock price at the time of disposal.

- In Item 6 above, the method of disposition involves the transfer from the company's treasury account to the accounts of designated employees

- In Item 10 above, all Audit Committee members are Independent Directors (all Audit Committee members were in attendance)

- In Item 11 above, the daily sell order quantity limit is not applicable, as the shares will not be sold through on-market transaction on the securities market

- Holding status of treasury shares before purchase

(Number of shares)

Stock type

Initial quantity

Changes

End quantity

Purchase

Disposal

Cancellation

Common

91,828,987

17,297,034

1,152,022

-

107,973,999

Other

13,603,461

-

-

-

13,603,461

- The 'Initial quantity' represents the number of shares held on as of January 1, 2026, the first day of the fiscal year in which the disclosure document was prepared; and the 'End quantity' refers to the number of shares held on January 29, 2026, the day the disclosure document was prepared.

 

Additional disclosure items

1. Relationship to the company or the largest shareholder by each counterparty to transaction

- Employees, etc., of the Company

2. Reason for selecting the counterparty to transaction

- The company agreed to deliver shares upon the payment of 2025 OPI and LTI to align the interests of shareholders and employees and to promote mid-to-long-term growth

3. Number of shares to be disposed of (shrs.) by each counterparty to transaction

- 6,729,069 common shares

4. Price calculation basis

- The number of shares to be disposed in Item 1, the price of shares to be disposed in Item 2 and the value of shares to be disposed in Item 3 were calculated based on the closing price on the day of the Board's resolution (January 28, 2026). However, the actual number of shares disposed of, the stock price, and the total disposal amount may be subject to change

5. Expected dilution

- The number of shares to be disposed in Item 1 above represent approximately 0.114% of the total number of issued shares (5,919,637,922 common), and the dilutive effect on share value is expected to be insignificant

6. Other matters to be factored into investment decisions

 - Of the 6,729,069 shares to be disposed, the number of shares subject to selling restrictions is as follows:

6,596,331 shares subject to a one-year selling restriction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUPPGUPQURB
Date   Source Headline
30th Jun 202210:01 amRNSSustainability Report 2022
31st May 202211:43 amRNSCorporate Governance Report FY2021
31st May 202211:02 amRNS2022 1Q Interim Business Report
18th May 202210:26 amRNSEarly Termination of Independent Director’s Term
29th Apr 20222:50 pmRNS2021 Business Report
28th Apr 202210:01 amRNSTransactions with Affiliated Companies
28th Apr 20229:49 amRNSTransactions with Affiliated Companies
28th Apr 20229:44 amRNSCharitable Contribution
28th Apr 20229:29 amRNSQuarterly Dividend for First Quarter 2022
28th Apr 20229:24 amRNS2022 1Q Earnings Release
21st Apr 20229:18 amRNSEarly Termination of Independent Director’s Term
21st Apr 20228:49 amRNSEarly Termination of Independent Director’s Term
7th Apr 20229:35 amRNSNotice of 1Q 2022 Earnings Release Schedule
7th Apr 20229:32 amRNS1Q 2022 Pre-Earnings Guidance
16th Mar 20229:10 amRNSTransaction with Affiliate Company
16th Mar 20229:08 amRNSAppointment of New Chief Executive Officer
16th Mar 20229:06 amRNSResults of the 53rd Annual General Meeting
17th Feb 202210:18 amRNSReference Material for 2022 AGM
17th Feb 20228:40 amRNS2021 Separate Financial Statements
17th Feb 20228:30 amRNS2021 Consolidated Financial Statements
15th Feb 202211:35 amRNSReference Material for 2022 AGM
15th Feb 202211:24 amRNSTransaction with Affiliate Company
15th Feb 202211:21 amRNSAppointment of New Chief Executive Officer
15th Feb 202211:16 amRNSCharitable Contribution
27th Jan 20227:05 amRNSYear-End Dividend for FY2021
27th Jan 20227:00 amRNS2021 4Q Earnings Release
7th Jan 20227:00 amRNS4Q 2021 Pre-Earnings Guidance
7th Jan 20227:00 amRNSNotice of 4Q 2021 Earnings Release Schedule
1st Dec 202110:03 amRNSCharitable Contributions
30th Nov 202112:52 pmRNS2021 3Q Interim Business Report
30th Nov 202111:15 amRNSTransactions with Affiliated Companies
24th Nov 20218:11 amRNSInvestment in Fabrication Plant
10th Nov 20217:55 amRNSAnnouncement of Investor Relations Event
28th Oct 20218:22 amRNSCharitable Contribution
28th Oct 20218:18 amRNSTransaction with Affiliate Company
28th Oct 20218:04 amRNSTransaction with Affiliate Company
28th Oct 20218:03 amRNSQuarterly Dividend for Third Quarter 2021
28th Oct 20217:59 amRNS2021 3Q Earnings Release
8th Oct 20218:05 amRNSNotice of 3Q 2021 Earnings Release Schedule
8th Oct 20218:04 amRNS3Q 2021 Pre-Earnings Guidance
31st Aug 202110:39 amRNS2021 Half-year Business Report
29th Jul 20218:12 amRNSRenewal of Property & Casualty Insurance Policy
29th Jul 20218:07 amRNSQuarterly Dividend for Second Quarter 2021
29th Jul 20218:06 amRNS2021 2Q Earnings Release
7th Jul 20218:25 amRNSNotice of 2Q 2021 Earnings Release Schedule
7th Jul 20218:17 amRNS2Q 2021 Pre-Earnings Guidance
6th Jul 202110:04 amRNSSustainability Report 2021
1st Jun 20217:00 amRNS2021 1Q Interim Report
1st Jun 20217:00 amRNSCorporate Governance Report FY2020
20th May 20219:20 amRNS2020 Separate Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.